Skip to content

Clinical trials

Phase 3 trials in Zambia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: Zambia Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20062
20071
20082
20092
20104
20111
20121
20151
20162
20181
20194
20202
20211
20221
20232
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting5
Terminated2
Withdrawn2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NICHD Global Network for Women's and Children's Health6
Institute of Tropical Medicine, Belgium4
London School of Hygiene and Tropical Medicine3
ANRS, Emerging Infectious Diseases2
French National Agency for Research on AIDS and Viral Hepatitis2
Global Alliance for TB Drug Development2
Johns Hopkins Bloomberg School of Public Health2
Pfizer2
Population Health Research Institute2
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections7
Malaria6
Tuberculosis4
COVID-193
Acquired Immunodeficiency Syndrome2
Anemia2
Asphyxia Neonatorum2
Herpes Genitalis2
Hypoxia-Ischemia, Brain2
Premature Birth2

Trials

Showing 76 to 39 of 39. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.